Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Terbutaline Sulfate is used to prevent and to reverse bronchospasm in patients 12 years of age and older. It is given for asthma, and also for reversible bronchospasm linked with bronchitis and emphysema.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Terbutaline is a relatively selective β2-adrenergic bronchodilator, with little or no effect on alpha-adrenergic receptors. It has a preferential effect on β2-adrenergic receptors, but it stimulates beta-adrenergic receptors less selectively than the relatively selective β2-agonists do. Terbutaline appears to act more strongly on the beta-receptors of bronchial, vascular and uterine smooth muscle (β2 receptors) than on the beta-receptors of the heart (β1 receptors). The medicine relaxes smooth muscle and inhibits uterine contractions, but it may also cause some cardiostimulatory effects and CNS stimulation. Its pharmacologic effects are at least in part due to stimulation, through beta-adrenergic receptors, of intracellular adenyl cyclase. This is the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (c-AMP). Higher c-AMP levels are associated with relaxation of bronchial smooth muscle and with inhibition of the release of mediators of immediate hypersensitivity from cells, especially mast cells.

Pregnancy & Breastfeeding

Animal studies and patient experience have shown no teratogenic effects, but Terbutaline should still be given with caution during the first trimester of pregnancy. Terbutaline passes into breast milk. At therapeutic doses, though, an effect on the infant is unlikely.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Terbutaline sulfate tablets and syrup, used in bronchospasm, act for 7 to 8 hours, so the minimum recommended dosage interval is 7 hours. For adults and the elderly, the tablet dose during the first 1 to 2 weeks is 2.5 mg (1 tablet) 3 times in a 24 hour period. The dose may then be increased to 5 mg (2 tablets) 3 times in 24 hours to achieve adequate bronchodilation. With the syrup, the starting dose should be 2×5 ml spoonfuls (3 mg) 3 times in 24 hours, and if necessary it may be increased to 3×5 ml spoonfuls (4.5 mg) 3 times in 24 hours. For children aged 7 to 15 years, the starting tablet dose should normally be 2.5 mg (1 tablet) 2 times in 24 hours. Some patients may need 2.5 mg (1 tablet) 3 times in 24 hours. The syrup dose for children is 0.25 ml (0.075 mg)/kg body weight 3 times in a 24 hour period. The recommended nebuliser solution dose for adults is 1 to 2 Respules, 2 to 4 times a day. Children over 8 years take 1 Respule, 2 to 4 times a day. Younger children are usually prescribed lower doses.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.